PMA P150003S065

Device
SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System and SYNERGY XD Everolimus-Eluting Platinum Chromium C
Applicant
Boston Scientific Corporation
PMA number
P150003
Supplement
S065
Product code
NIQ
Decision date
2020-10-13
Generic name
Coronary drug-eluting stent
Approval order statement
Additional of two UV Bonders to the catheter manufacturing lines.

Current openFDA PMA Record#

Device
SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System and SYNERGY XD Everolimus-Eluting Platinum Chromium C
Applicant
Boston Scientific Corporation
PMA number
P150003
Supplement
S065
Product code
NIQ
Generic name
Coronary drug-eluting stent
Decision date
2020-10-13
Decision code
OK30
Date received
2020-09-29
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Additional of two UV Bonders to the catheter manufacturing lines.